PRODUITS DERIVES DE 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE SUBSTITUES, UTILES POUR LE TRAITEMENT DE TROUBLES HYPERLIFERATIFS ET DE MALADIES ASSOCIEES A UNE ANGIOGENESE

• 收藏
• 分享

专利权人:

BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

发明人:

HENTEMANN, MARTIN,WOOD, JILL,SCOTT, WILLIAM,MICHELS, MARTIN,CAMPBELL, ANN-MARIE,BULLION, ANN-MARIE,ROWLEY, R. BRUCE,REDMAN, ANIKO

申请号：

CA2671614

公开号：

CA2671614C

申请日:

2007.12.05

申请国别(地区):

CA

年份:

2016

代理人:

摘要：

This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/